Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO was delisted on the 16th of December, 2016.
5 hedge funds and large institutions have $39K invested in Northwest Biotherapeutics, Inc. Common stock in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
8% more capital invested
Capital invested by funds: $36K → $39K (+$3K)
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$1K |
| 2 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$344 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$16K |
| 2 |
MPI
Mairs & Power Inc
St Paul,
Minnesota
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WJWM
1
Williams Jones Wealth Management
New York
| $17K | – | – | – |
|
|
MSAM
2
Moloney Securities Asset Management
Manchester,
Missouri
| $11K | +$344 | +1,000 | +3% |
|
|
LDB
3
Lee, Danner & Bass
Nashville,
Tennessee
| $7K | – | – | – |
|
|
OCG
4
Opus Capital Group
Cincinnati,
Ohio
| $3K | – | – | – |
|
|
5
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1K | +$1K | +2,162 | New |
|
|
6
Victory Capital Management
San Antonio,
Texas
| – | -$16K | -101,003 | Closed |
|
|
MPI
7
Mairs & Power Inc
St Paul,
Minnesota
| – | -$2K | -12,500 | Closed |
|
NWBO Hedge Fund Activity: Q2 2020 in Review
5 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. Common stock (NWBO) for Q2 2020, worth a combined $39K — up 8.3% from $36K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NWBO and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $1K. The largest seller was Victory Capital Management, exiting entirely with an estimated $16K sold.
- 5 institutional investors held Northwest Biotherapeutics, Inc. Common stock (NWBO) as of Q2 2020, down from 6 in Q1 2020.
- Funds reported $39K of Northwest Biotherapeutics, Inc. Common stock stock for Q2 2020, up 8.3% quarter-over-quarter.
- 1 fund opened new Northwest Biotherapeutics, Inc. Common stock positions in Q2 2020 and 2 closed out, a net change of -1 holder.
- The largest Northwest Biotherapeutics, Inc. Common stock buyer in Q2 2020 was CAPTRUST Financial Advisors, an estimated $1K added.
- The largest Northwest Biotherapeutics, Inc. Common stock seller in Q2 2020 was Victory Capital Management, an estimated $16K sold.
Based on aggregated 13F filings for Q2 2020.